Literature DB >> 19694309

Quality assurance in forensic pathology.

Beng Beng Ong1, Nathan Milne.   

Abstract

One of the requirements for proper running of a pathology laboratory is implementation of a quality assurance programme. Forensic pathology is not exempted, especially so when cases are increasing in complexity. It is not difficult to introduce a quality assurance programme even in a small forensic centre. Among the steps that can be implemented including introduction of a set of minimal standards in performance of the autopsy, timeliness and report writing, a vigorous peer review process either internally or externally and participation in external quality programmes. Proper documentation of the post-mortem process (photography, slides and blocks and various imaging modalities) is to be encouraged. There should be limits set on workload of pathologists as overburden is known to lower standards. A pleasant work environment is also essential. Personal continuous medical education should be made mandatory. Introduction of a quality assurance programme will not only improve standards but minimise possible negligence. The post-mortem reports will be seen to carry more weight in court.

Mesh:

Year:  2009        PMID: 19694309

Source DB:  PubMed          Journal:  Malays J Pathol        ISSN: 0126-8635            Impact factor:   0.656


  3 in total

1.  Identifying Errors in Forensic Autopsy Reports Using a Novel Web-Based Program.

Authors:  Matthew D Cain; Jason Brazelton; Daniel W Dye
Journal:  Acad Forensic Pathol       Date:  2016-03-01

Review 2.  A review of causal inference in forensic medicine.

Authors:  Putri Dianita Ika Meilia; Michael D Freeman; Maurice P Zeegers
Journal:  Forensic Sci Med Pathol       Date:  2020-03-10       Impact factor: 2.007

Review 3.  A review of the diversity in taxonomy, definitions, scope, and roles in forensic medicine: implications for evidence-based practice.

Authors:  Putri Dianita Ika Meilia; Michael D Freeman; Maurice P Zeegers
Journal:  Forensic Sci Med Pathol       Date:  2018-10-02       Impact factor: 2.007

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.